Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)

SHE:301096 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,472	4,115	7,091	7,389	9,293	-
Market Cap Growth	-51.57%	-41.97%	-4.04%	-20.49%	-	-
Enterprise Value	6,791	4,256	6,460	6,057	9,416	-
Last Close Price	59.68	37.94	64.78	67.17	83.80	-
PE Ratio	-	-	26.07	38.06	83.65	-
Forward PE	121.80	12.33	21.10	26.68	-	-
PS Ratio	9.05	5.13	6.97	12.17	24.83	-
PB Ratio	2.54	1.60	2.64	2.98	4.01	-
P/TBV Ratio	2.63	1.66	2.74	3.08	4.12	-
P/OCF Ratio	-	-	78.39	28.48	63.90	-
EV/Sales Ratio	9.50	5.31	6.35	9.97	25.15	-
EV/EBITDA Ratio	222.42	43.41	18.51	33.90	67.75	-
EV/EBIT Ratio	-	-	24.75	49.50	84.55	-
Debt / Equity Ratio	0.33	0.28	0.14	0.00	0.12	0.45
Debt / EBITDA Ratio	28.22	7.23	1.05	0.05	1.93	2.18
Asset Turnover	0.19	0.22	0.31	0.21	0.21	0.41
Inventory Turnover	2.46	2.88	4.42	4.46	9.26	23.08
Quick Ratio	1.53	1.64	1.68	5.15	4.53	1.66
Current Ratio	1.90	2.01	1.90	5.54	4.71	1.96
Return on Equity (ROE)	-4.87%	-2.01%	10.53%	8.09%	8.35%	18.48%
Return on Assets (ROA)	-2.11%	-0.77%	4.95%	2.61%	3.91%	6.60%
Return on Capital (ROIC)	-2.38%	-0.90%	5.88%	3.00%	4.50%	8.69%
Return on Capital Employed (ROCE)	-	-	9.20%	4.60%	4.50%	10.40%
Earnings Yield	-1.99%	-1.28%	3.84%	2.63%	1.20%	-
FCF Yield	-5.47%	-14.36%	-8.44%	-4.50%	-1.11%	-
Dividend Yield	-	-	0.46%	1.19%	0.72%	-
Payout Ratio	-	-	34.12%	34.28%	9.11%	15.20%
Buyback Yield / Dilution	0.17%	0.66%	0.11%	-33.77%	-0.29%	-9.26%
Total Shareholder Return	-	0.66%	0.57%	-32.58%	0.42%	-9.26%

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.